Literature DB >> 31517484

Conformational Dynamics of AcrA Govern Multidrug Efflux Pump Assembly.

Anthony J Hazel1, Narges Abdali2, Inga V Leus2, Jerry M Parks3, Jeremy C Smith3,4, Helen I Zgurskaya2, James C Gumbart1.   

Abstract

Multidrug efflux pumps of pathogenic, Gram-negative bacteria comprise an innate resistance mechanism and are key contributors to the emerging global pandemic of antibiotic resistance. Several increasingly detailed cryo-electron microscopy maps have been resolved of an entire efflux pump complex, AcrAB-TolC, resulting in atomistic structural models. Using a recent model, we have carried out nearly 40 μs of molecular dynamics simulations to study one of the key components of the protein complex AcrA, the membrane fusion protein that connects the inner-membrane-bound AcrB to the outer-membrane-bound TolC. We determined a three-dimensional potential of mean force (PMF) for AcrA, which displays two main conformational basins representing assembly competent and incompetent states. Corresponding experiments show that stabilizing mutations at an interdomain interface shift the dynamic equilibrium between these states to the incompetent one, disrupting pump assembly and function and resensitizing bacteria to existing antibiotics. The modulation of AcrA dynamics through pharmacological intervention therefore presents a promising route for the development of new antibiotics.

Entities:  

Keywords:  Gram-negative bacteria; antibiotic resistance; efflux pump; free-energy calculations; molecular dynamics simulations

Year:  2019        PMID: 31517484      PMCID: PMC7301636          DOI: 10.1021/acsinfecdis.9b00273

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  44 in total

1.  Interaction between the TolC and AcrA proteins of a multidrug efflux system of Escherichia coli.

Authors:  Fasahath Husain; Matthew Humbard; Rajeev Misra
Journal:  J Bacteriol       Date:  2004-12       Impact factor: 3.490

Review 2.  Efflux pumps as antimicrobial resistance mechanisms.

Authors:  Keith Poole
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

3.  Conformational flexibility in the multidrug efflux system protein AcrA.

Authors:  Jonathan Mikolosko; Kostyantyn Bobyk; Helen I Zgurskaya; Partho Ghosh
Journal:  Structure       Date:  2006-03       Impact factor: 5.006

4.  The assembled structure of a complete tripartite bacterial multidrug efflux pump.

Authors:  Martyn F Symmons; Evert Bokma; Eva Koronakis; Colin Hughes; Vassilis Koronakis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-02       Impact factor: 11.205

5.  Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.

Authors:  Narges Abdali; Jerry M Parks; Keith M Haynes; Julie L Chaney; Adam T Green; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerome Baudry; Jeremy C Smith; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2016-11-02       Impact factor: 5.084

6.  Distribution of mechanical stress in the Escherichia coli cell envelope.

Authors:  Hyea Hwang; Nicolò Paracini; Jerry M Parks; Jeremy H Lakey; James C Gumbart
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-09-29       Impact factor: 3.747

7.  Chimeric analysis of AcrA function reveals the importance of its C-terminal domain in its interaction with the AcrB multidrug efflux pump.

Authors:  Christopher A Elkins; Hiroshi Nikaido
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

8.  Engineered disulfide bonds support the functional rotation mechanism of multidrug efflux pump AcrB.

Authors:  Markus A Seeger; Christoph von Ballmoos; Thomas Eicher; Lorenz Brandstätter; François Verrey; Kay Diederichs; Klaas M Pos
Journal:  Nat Struct Mol Biol       Date:  2008-01-27       Impact factor: 15.369

Review 9.  Drug transport mechanism of the AcrB efflux pump.

Authors:  Klaas M Pos
Journal:  Biochim Biophys Acta       Date:  2009-01-03

10.  Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.

Authors:  Ganesh Krishnamoorthy; Inga V Leus; Jon W Weeks; David Wolloscheck; Valentin V Rybenkov; Helen I Zgurskaya
Journal:  MBio       Date:  2017-10-31       Impact factor: 7.867

View more
  12 in total

1.  A "Drug Sweeping" State of the TriABC Triclosan Efflux Pump from Pseudomonas aeruginosa.

Authors:  Lucien Fabre; Abigail T Ntreh; Amira Yazidi; Inga V Leus; Jon W Weeks; Sudipta Bhattacharyya; Jakob Ruickoldt; Isabelle Rouiller; Helen I Zgurskaya; Jurgen Sygusch
Journal:  Structure       Date:  2020-09-22       Impact factor: 5.006

2.  Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold.

Authors:  Adam T Green; Mohammad Moniruzzaman; Connor J Cooper; John K Walker; Jeremy C Smith; Jerry M Parks; Helen I Zgurskaya
Journal:  Biochim Biophys Acta Gen Subj       Date:  2020-02-04       Impact factor: 3.770

3.  Structure, Assembly, and Function of Tripartite Efflux and Type 1 Secretion Systems in Gram-Negative Bacteria.

Authors:  Ilyas Alav; Jessica Kobylka; Miriam S Kuth; Klaas M Pos; Martin Picard; Jessica M A Blair; Vassiliy N Bavro
Journal:  Chem Rev       Date:  2021-04-28       Impact factor: 60.622

4.  Lpp positions peptidoglycan at the AcrA-TolC interface in the AcrAB-TolC multidrug efflux pump.

Authors:  James C Gumbart; Josie L Ferreira; Hyea Hwang; Anthony J Hazel; Connor J Cooper; Jerry M Parks; Jeremy C Smith; Helen I Zgurskaya; Morgan Beeby
Journal:  Biophys J       Date:  2021-08-17       Impact factor: 3.699

5.  Mechanistic Duality of Bacterial Efflux Substrates and Inhibitors: Example of Simple Substituted Cinnamoyl and Naphthyl Amides.

Authors:  Napoleon D'Cunha; Mohammad Moniruzzaman; Keith Haynes; Giuliano Malloci; Connor J Cooper; Enrico Margiotta; Attilio V Vargiu; Muhammad R Uddin; Inga V Leus; Feng Cao; Jerry M Parks; Valentin V Rybenkov; Paolo Ruggerone; Helen I Zgurskaya; John K Walker
Journal:  ACS Infect Dis       Date:  2021-08-11       Impact factor: 5.578

6.  A genetic platform to investigate the functions of bacterial drug efflux pumps.

Authors:  Tanisha Teelucksingh; Laura K Thompson; Shawna Zhu; Noah M Kuehfuss; James A Goetz; Stephanie E Gilbert; Craig R MacNair; Jennifer Geddes-McAlister; Eric D Brown; Georgina Cox
Journal:  Nat Chem Biol       Date:  2022-09-05       Impact factor: 16.174

7.  The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux.

Authors:  Valentin V Rybenkov; Helen I Zgurskaya; Chhandosee Ganguly; Inga V Leus; Zhen Zhang; Mohammad Moniruzzaman
Journal:  Chem Rev       Date:  2021-02-17       Impact factor: 60.622

8.  Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.

Authors:  Helen I Zgurskaya; John K Walker; Jerry M Parks; Valentin V Rybenkov
Journal:  Acc Chem Res       Date:  2021-02-04       Impact factor: 22.384

9.  Molecular rationale for the impairment of the MexAB-OprM efflux pump by a single mutation in MexA.

Authors:  Pierpaolo Cacciotto; Andrea Basciu; Francesco Oliva; Giuliano Malloci; Martin Zacharias; Paolo Ruggerone; Attilio V Vargiu
Journal:  Comput Struct Biotechnol J       Date:  2021-12-03       Impact factor: 7.271

10.  MexAB-OprM Efflux Pump Interaction with the Peptidoglycan of Escherichia coli and Pseudomonas aeruginosa.

Authors:  Miao Ma; Margaux Lustig; Michèle Salem; Dominique Mengin-Lecreulx; Gilles Phan; Isabelle Broutin
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.